Lack of Stability of Aggregates after Thrombin-Induced Reaggregation of Thrombin-Degranulated Platelets

Summary

The stability of platelet aggregates is influenced by the extent of the release of granule contents; if release is extensive and aggregation is prolonged, deaggregation is difficult to achieve. The relative importance of the contributions of released substances to aggregate stability are not known, although stable thrombin-induced aggregates form in platelet-rich plasma from patients with barely detectable plasma or platelet fibrinogen, and ADP stabilizes thrombin-induced aggregates of platelets from patients with delta storage pool deficiency which otherwise deaggregate more readily than normal platelets. We degranulated platelets with thrombin (0.9 U/ml caused greater than 90% loss of delta and alpha granule contents) and recovered them as individual platelets in fresh medium. The degranulated platelets were reaggregated by thrombin (2 U/ml). To prevent continuing effects of thrombin, FPRCH₂C1 was added when thrombin-induced aggregation of thrombin-degranulated platelets reached its maximum. EDTA (5 mM) or EGTA (5 mM) added at maximum aggregation did not deaggregate these platelets, indicating that the stability of these aggregates does not depend on Ca²⁺ in the medium. Whereas with control platelets a combination of PGE₁ (10 μM) and chymotrypsin(10 U/ml) was required for deaggregation, with thrombin-degranulated platelets either PGE₁ or chymo-trypsin alone caused extensive deaggregation. The rate and extent of deaggregation of thrombin-degranulated platelets by a combination of PGE₁ and chymotrypsin was greater than with control platelets.

Electron microscope gold immunocytochemistry using antihuman fibrinogen IgG, anti-von Willebrand factor and anti-fibronectin showed a) that fibrinogen in the vacuoles of degranulated platelets was visible at focal points of platelet contact in the aggregates, but that large areas of platelet contact had no fibrinogen detectable between them; and b) in comparison to fibrinogen, little fibronectin or von Willebrand factor (vWf) was detectable in the platelets.

Since the linkages between thrombin-degranulated platelets reaggregated by thrombin can be disrupted either by raising cAMP (thus making glycoprotein IIb/IIIa unavailable) or by proteolysis, these linkages are less stable than those formed between normal platelets. It might therefore be expected that platelets that take part in thrombus formation and then recirculate are likely to form less stable thrombi than platelets that have not released their granule contents.

• References

• 1 Kinlough-Rathbone RL, Mustard JF, Perry DW, Dejana E, Cazenave J-P, Packham MA, Harfenist EJ. Factors influencing the deaggregation of human and rabbit platelets. Thromb Haemostas 1983; 49: 162-167
• 2 Kinlough-Rathbone RL, Perry DW, Packham MA, Mustard JF. Deaggregation of human platelets aggregated by thrombin. Thromb Haemostas 1985; 53: 42-44
• 3 Soria J, Soria C, Borg JY, Mirshahi M, Piguet H, Tron P, Fessard C, Caen JP. Platelet aggregation occurs in congenital afibrinogenaemia despite the absence of fibrinogen or its fragments in plasma and platelets, as demonstrated by immunoenzymology. Br J Haematol 1985; 60: 503-514
• 4 Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham MA, Mustard JF. Fibrinogen-independent aggregation and deaggregation of human platelets: studies in two afibrinogenemic patients. Blood 1987; 70: 221-226
• 5 Cattaneo M, Canciani MT, Kinlough-Rathbone RL, Packham MA, Mannucci PM, Mustard JF. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood 1990; 75: 1081-1086
• 6 Molnar J, Lorand L. Studies on apyrases. Arch Biochem Biophys 1961; 93: 353-363
• 7 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204
• 8 Kinlough-Rathbone RL, Packham MA, Mustard JF. Platelet aggregation. In: Methods in Hematology. Measurements of Platelet Function. Harker LA, Zimmerman TS. (eds) Churchill Livingstone; Edinburgh: 1983. pp 64-91
• 9 Kinlough-Rathbone RL, Packham MA, Guccione MA, Richardson M, Harfenist EJ, Mustard JF. Characteristics of thrombin-degranulated human platelets; development of a method that does not use proteolytic enzymes for deaggregation. Thromb Haemostas 1991; 65: 403-410
• 10 Greenberg J, Packham MA, Cazenave J-P, Reimers H-J, Mustard JF. Effects on platelet function of removal of platelet sialic acid by neuraminidase. Lab Invest 1975; 32: 476-484
• 11 Suzuki H, Kinlough-Rathbone RL, Packham MA, Tanoue K, Yamazaki H, Mustard JF. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels. Blood 1988; 71: 850-860
• 12 Danscher G, Norgaard JOR. Light microscopic visualization of colloidal gold on resin-embedded tissue. J Histochem Cytochem 1983; 31: 1394-1398
• 13 Shuman MA, Botney M, Fenton II JW. Thrombin-induced platelet secretion. Further evidence for a specific pathway. J Clin Invest 1979; 63: 1211-1218
• 14 Vu T-K H, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
• 15 Aktories K, Jakobs KH. Nj-mediated inhibition of human platelet adenylate cyclase by thrombin. Eur J Biochem 1984; 145: 333-338
• 16 Defreyn G, Gachet C, Savi P, Driot F, Cazenave JP, Maffrand JP. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE_ractivated platelet adenylate cyclase in rats and rabbits. Thromb Haemostas 1991; 65: 186-190
• 17 Wencel-Drake J. Plasma membrane GP IIb/IIIa. Evidence for a recycling receptor pool. Am J Pathol 1990; 136: 61-70
• 18 Legrand C, Dubernard V, Nurden AT. Studies on the mechanism of expression of secreted fibrinogen on the surface of activated human platelets. Blood 1989; 73: 1226-1234
• 19 Suzuki H, Kinlough-Rathbone RL, Packham MA, Tanoue K, Yamazaki H, Mustard JF. Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets. Blood 1988; 71: 1310-1320
• 20 Heilmann E, Hourdille P, Pruvost A, Paponneau A, Nurden AT. Thrombin-induced platelet aggregates have a dynamic structure. Time-dependent redistribution of glycoprotein IIb-IIIa complexes and secreted adhesive proteins. Arteriosclerosis Thromb 1991; 11: 704-718
• 21 Suzuki H, Katagiri Y, Tsukita S, Tanoue K, Yamazaki H. Localization of adhesive proteins in two newly subdivided zones in electron-lucent matrix of human platelet a-granules. Histochemistry 1990; 94: 337-344
• 22 Mosesson MW, Umfleet RA. The cold-insoluble globulin of human plasma. I. Purification, primary characterization, and relationship to fibrinogen and other cold-insoluble fraction components. J Biol Chem 1970; 245: 5728-5736
• 23 Ruoslahti E, Vaheri A. Interaction of soluble fibroblast surface antigen with fibrinogen and fibrin. Identity with cold-insoluble globulin of human plasma. J Exp Med 1975; 141: 497-501
• 24 Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Orr JL, Kinlough-Rathbone RL, Perry DW, Mustard JF. Effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood 1979; 54: 753-765
• 25 Guccione MA, Kinlough-Rathbone RL, Packham MA, Harfenist EJ, Rand ML, Greenberg JP, Perry DW, Mustard JF. Effects of plasmin on rabbit platelets. Thromb Haemostas 1985; 53: 8-14